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determine the mechanisms underlying this relation.
Limitations of this study include its small sample size and
the limited statistical power to detect true differences and
relationships. Given the interrelatedness of patient- and
procedure-related characteristics, large samples are needed
to determine which variables are driving observed effects.
Despite the frequent use of DHCA in this patient cohort,
few children had an rSO2 below 40 or a decrease from base-
line of 40% or more, resulting in limited statistical power to
compare children above and below the specified levels. Al-
though we had planned to also calculate cumulativeminutes
below 40%, 30%, and 20% saturation, these variables were
eliminated owing to the low number of participants whose
rSO2 dropped below the specified levels. It should be noted
that almost half of the participants in this study had multiple
operations and hospitalizations; therefore, whereas the pri-
mary focus of this study was on the specific operation dur-
ing which the patient received NIRS monitoring, it is
possible that events occurring during other operative proce-
dures affected neurodevelopmental outcomes at 24 months
of age. In addition, although neurodevelopmental outcomes
could be influenced by events at any time in the periopera-
tive period, NIRS values were only monitored during the
surgical procedure. Therefore, important events that may
have played a role in neurodevelopmental outcomes could
have gone undetected.
In conclusion, despite the intuitive appeal of rSO2 moni-
toring by NIRS during cardiac surgery, the predictive value
of NIRS for neurodevelopmental outcome remains unclear.
As suggested by these preliminary data, the predictive value
of NIRS may vary for different neurodevelopmental do-
mains, and it seems likely that this type of monitoring
may prove to be most useful in patients subjected to cyano-
sis, hemodynamic instability, and repeated interventions,
a population commonly perceived to be at highest risk for
neurodevelopmental impairment.
We thank Mrs Carol Prospero for her assistance in coordinating
this study.References
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Dr James S. Tweddell (Milwaukee, Wis).My thanks to the au-
thors for sending me their manuscript well in advance of this
meeting.
The authors have performed a prospective observational study
of infants less than 1 year of age looking for factors predicting neu-
rodevelopmental outcome and have included intraoperative NIRS
among those factors tested. They have found that the Bayley scores
were predicted by a large number of factors such as hospital length
of stay, prematurity, birth weight, length of stay in the cardiac in-
tensive care unit, and comorbidities. Only in the area of receptive
communication was the cerebral saturation found to be predictive.
Just for everyone’s benefit, could you explain to us what that par-
ticular domain, receptive communication, measures and its prog-
nostic importance?
Dr Sood. Absolutely. It measures receptive language—how
much language the child understands. Unlike expressive commu-
nication, we are not looking at what the child can actually commu-
nicate but instead what he or she understands. For example, a child
looks at a book of pictures and is asked to point to the ball, the toy,
the bear. Also, the child is observed interacting with the caregiver
and the examiner to see how well he or she responds. And your
next question refers to the predictive value?
Dr Tweddell. The prognostic significance.
Dr Sood.What we know is that, at 2 years of age, Bayley scores
do not correlate highly with later intelligence for most children.
The Bayley-III is a measure of development, rather than intelli-
gence. Intelligence is thought to be stable, whereas development
is characterized by spurts and lags. However, for children who
have known deficits, children who are below the average range,
the predictive value tends to be better. For these children, the Bay-
ley is more predictive of impairment later on in childhood and in
adulthood.
Dr Tweddell. Thank you. I want to emphasize here that the au-
thors have looked only at the intraoperative NIRS. The basicrdiovascular Surgery c Volume 143, Number 1 123
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mize or prevent cerebral ischemia that could result in neurologic
impairment. Certainly the operating room is one of those arenas
where that could occur, but it could also occur in other places, in
the case of neonates in the newborn nursery, and for all the patients
in the postoperative care unit. Patients can have a decrease in ce-
rebral oxygenation at any time during the hospitalization, and
any of those episodes could affect their neurodevelopmental out-
come. Particularly in this study, you identified events outside the
operating room, such as length of stay in the cardiac intensive
care unit and total hospital length of stay, as important factors.
Your study suggests that there might be other times when the pa-
tient is vulnerable.
Dr Sood. Absolutely.
Dr Tweddell. You also have included a heterogeneous popula-
tion, and this may be a strength or a weakness. In previous studies
in which NIRS was found to more strongly predict neurodevelop-
mental outcome, the patient populations studied were more uni-
form than in your study. In our own studies, we have included
primarily neonates with a single diagnosis, hypoplastic left heart
syndrome. In the recent publication from Boston, the study popu-
lation comprised patients undergoing 2-ventricle repair. In both
cases the study groups were fairly uniform, and perhaps that
improves the likelihood of identifying an impact of NIRS by min-
imizing the impact of confounding factors such as arterial satura-
tion and perfusion temperature.
How is the rSO2 nadir determined? Was that the lowest value?
Dr Sood. Yes, it was the lowest value during surgery.
Dr Tweddell. It was not the inflection point of the decay slope
or anything like that?
Dr Sood. Correct.
Dr Tweddell. Okay. How long did you have to stay at that level
before it became your nadir?
Dr Sood. You just had to reach that level.
DrTweddell.All right. Thank you.What constituted significant
comorbidities? Were there any neurologic injuries in that group?
Dr Sood. Comorbidities included restrictive atrial septal defect,
prematurity less than 35 weeks’ gestational age, arrhythmias, nec-
rotizing enterocolitis, seizures, depressed myocardial function,
history of prolonged mechanical ventilation, portal hypertension,
pneumonia, protein-losing enteropathy, right ventricular dysfunc-
tion, and pacemaker.
Dr Tweddell. Thank you. The seizures in particular could be
a neurodevelopmental outcome end point, too, couldn’t they?
You included both cyanotic and acyanotic children in your study,
and rSO2 is related to arterial saturation. How did you control or
account for that?
Dr Sood. We included preoperative cyanosis in univariable
analyses, and then we looked at what entered into stepwise regres-
sion analyses.
Dr Tweddell. Was that an anatomic diagnosis that determined
whether the child was cyanotic or was that a measure of arterial
saturation that determined cyanosis?
Dr Sood. That was a measure.
Dr Tweddell. Certainly if a child is profoundly cyanotic, the
rSO2 is going to be low as well, right? So it might be important
to control for that. I can certainly understand the drop to less
than 40% and the lowest value affecting neurodevelopmental124 The Journal of Thoracic and Cardiovascular Surgoutcome, but you found that a decrease to less than 20% of base-
line did not correlate with worse neurodevelopmental outcome.
Were those patients different in some way? Did they start off at
a higher baseline? Did you consider looking at or controlling for
baseline NIRS and how that correlated with outcome?
Dr Sood. This study did not focus on the baseline rSO2, but that
is certainly an area of future research.
Dr Tweddell. An rSO2 of 40% is a pretty widely accepted
threshold for cerebral ischemia at normothermia, but at deep hypo-
thermia it may not indicate adequate cerebral oxygenation. The
majority of your patients had DHCA. Did you do anything to con-
trol for temperature?
Dr Sood. We did not.
Dr Tweddell. The strengths of this paper include the measure-
ment of the potential benefit of NIRS as it is used in the typical
clinical situation with a broad spectrum of patients. Ultimately, I
think this analysis could benefit from the inclusion of NIRS data
from the entire hospitalization and controlling for differences in
baseline values, preoperative and postoperative cyanosis, and the
impact of deep hypothermia. This will be an important contribu-
tion and I thank you for allowing me to discuss it.
Dr Sood. Thank you.
Dr Pizarro. Bill, I just want to offer a couple explanations
about the methodology. One of the reasons we chose not to include
a specific patient population was that wewanted to try to discern, if
at all possible, what is the real contribution of NIRS into our deci-
sion making about how we conduct our clinical care in a real
world. I think that NIRS is being used in a number of institutions
across the board, not for monitoring of a specific subpatient pop-
ulation, but rather for everyone out there. So I think that the funda-
mental question was: How much do we learn from this insofar that
we could correlate with outcomes at least at 2 years of age? We
chose to use a most updated version of the Bayley scales that
will give us more domains to be tested and then try to discern
whether we could predict outcomes without making decisions
based on NIRS. I think the lesson is that, perhaps, if we would ex-
tend the limits of, for example, circulatory arrest, there would be
a far greater yield in trying to make predictions. For example,
100 minutes of circulatory arrest will definitely go along with
a very low value of NIRS and likely there will be a bad outcome.
But given what the current clinical practice is, we tried to learn
what the additional predictive value of NIRS is within the context
of standardized practice nowadays.
Dr J. William Gaynor (Philadelphia, Pa). I have a question
concerning management. Has this changed your practice? Do
you still record intraoperative NIRS? Do you act on intraoperative
NIRS? If not, why do you record it? Do you record NIRS in the
postoperative period and do you manage patients on the basis of
the postoperative NIRS? Has this changed your practice or what
you do at all?
Dr Pizarro. I will answer that. The answer is no, yes, no, and
no. That is, we continue to record as part of an ongoing study. I
think that we walked away from this learning and reaffirming
much of what your center and others have put forward, which is
the notion that there are many patient variables that really deter-
mine what the patients will look like when it comes to neurodeve-
lopmental testing later on. We are still accruing patients, including
intensive care unit stay NIRS, to have a far more in-depth analysis.ery c January 2012
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collection?
Dr Pizarro. Yes, we are doing it.
Dr Tweddell. Thank you.
DrConstantineMavroudis (Cleveland, Ohio).Was your ques-
tion intimating that this is a nice technology but maybe people do
not pay attention to it?
Dr Gaynor. I do not want to be the focus of the discussion.
Dr Mavroudis. But you already have been.
Dr Gaynor. There was a recent paper from Dean Andropoulos
at Texas Children’s where they used a very detailed neuromonitor-
ing program with transcranial Doppler sonography and NIRS in-
traoperatively, and they have a very detailed protocol to interact,
to respond to those changes. They have looked at preoperative
and postoperative brain magnetic resonance imaging. The mostThe Journal of Thoracic and Caimportant predictor of new injury was brain immaturity. None of
the NIRS variables that they measured correlated with outcome.
So my question is, will some centers actually use that number?
How is that number being used? If it is being recorded as part of
a research study, that’s one thing. If it is being recorded clinically
but not being acted on, that’s a different question.
Dr Mavroudis. My impression, and this is going to be anec-
dotal information on the basis of a worldwide survey, is that those
who use it will use it in the operating room. More than once I have
had a catheter in the wrong place, the anesthesiologist has alerted
me that the NIRS had fallen off, and I have adjusted the catheter. I
think we saved a significant problem there. So I think that the most
obvious answer to that question is, the information will be used in
the operating room. I rose to mention that because I suspect that
other people in the audience were thinking the same thing.rdiovascular Surgery c Volume 143, Number 1 125
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